Pattern of cerebral hyperperfusion in Alzheimer’s disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience

Purpose A three-dimensional (3D) continuous pulse arterial spin labeling (ASL) technique was used to investigate cerebral blood flow (CBF) changes in patients with Alzheimer’s disease (AD), amnestic mild cognitive impairment (aMCI), and age- and sex-matched healthy controls. Materials and methods Three groups were recruited for comparison, 24 AD patients, 17 MCI patients, and 21 age- and sex-matched control subjects. Three-dimensional ASL scans covering the entire brain were acquired with a 3.0 T magnetic resonance scanner. Spatial processing was performed with statistical parametric mapping 8. A second-level one-way analysis of variance analysis (threshold at P<0.05) was performed on the preprocessed ASL data. An average whole-brain CBF for each subject was also included as group-level covariates for the perfusion data, to control for individual CBF variations. Results Significantly increased CBF was detected in bilateral frontal lobes and right temporal subgyral regions in aMCI compared with controls. When comparing AD with aMCI, the major hyperperfusion regions were the right limbic lobe and basal ganglia regions, including the putamen, caudate, lentiform nucleus, and thalamus, and hypoperfusion was found in the left medial frontal lobe, parietal cortex, the right middle temporo-occipital lobe, and particularly, the left anterior cingulate gyrus. We also found decreased CBF in the bilateral temporo-parieto-occipital cortices and left limbic lobe in AD patients, relative to the control group. aMCI subjects showed decreased blood flow in the left occipital lobe, bilateral inferior temporal cortex, and right middle temporal cortex. Conclusion Our results indicated that ASL provided useful perfusion information in AD disease and may be used as an appealing alternative for further pathologic and neuropsychological studies, especially of compensatory mechanisms for cerebral hypoperfusion.

[1]  A. Burns Clinical diagnosis of Alzheimer's disease , 1991 .

[2]  Sue J. Kang,et al.  Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. , 2005, Brain : a journal of neurology.

[3]  Carlo Caltagirone,et al.  Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  K. Aytemir,et al.  Assessment of Endothelial Function in Alzheimer's Disease: Is Alzheimer's Disease a Vascular Disease? , 2007, Journal of the American Geriatrics Society.

[5]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[6]  L Bolinger,et al.  Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Ashford,et al.  Comparison of Neuropathologic Criteria for the Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[8]  Janet S. Reddin,et al.  Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease , 2011, Neurology.

[9]  G. Jahng,et al.  Regional cerebral perfusion in patients with Alzheimer’s disease and mild cognitive impairment: effect of APOE Epsilon4 allele , 2012, Neuroradiology.

[10]  Xiongwei Zhu,et al.  Vascular oxidative stress in Alzheimer disease , 2007, Journal of the Neurological Sciences.

[11]  S. Haber,et al.  The cortico-basal ganglia integrative network: The role of the thalamus , 2009, Brain Research Bulletin.

[12]  Jennifer L. Mozolic,et al.  Human Neuroscience , 2022 .

[13]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[14]  Gaohong Wu,et al.  Reliability and precision of pseudo‐continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O‐water PET in elderly subjects at risk for Alzheimer's disease , 2010, NMR in biomedicine.

[15]  Sterling C. Johnson,et al.  Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[16]  Seong Jin Cho,et al.  Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG , 2010, NeuroImage.

[17]  J T O'Brien,et al.  Role of imaging techniques in the diagnosis of dementia. , 2007, The British journal of radiology.

[18]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[19]  Denise C. Park,et al.  The adaptive brain: aging and neurocognitive scaffolding. , 2009, Annual review of psychology.

[20]  Xin Lou,et al.  Reliability of Three-Dimensional Pseudo-Continuous Arterial Spin Labeling MR Imaging for Measuring Visual Cortex Perfusion on Two 3T Scanners , 2013, PloS one.

[21]  Janet S. Reddin,et al.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.

[22]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[23]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[24]  Yaakov Stern,et al.  Multivariate and Univariate Analysis of Continuous Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[26]  David C. Alsop,et al.  Hippocampal hyperperfusion in Alzheimer's disease , 2008, NeuroImage.

[27]  S. Belleville,et al.  Compensation and Disease Severity on the Memory-Related Activations in Mild Cognitive Impairment , 2010, Biological Psychiatry.

[28]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[29]  Daniel Rueckert,et al.  Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease , 2012, NeuroImage.

[30]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[31]  K. Rockwood,et al.  Advances in perfusion magnetic resonance imaging in Alzheimer's disease , 2011, Alzheimer's & Dementia.

[32]  B J Shepstone,et al.  Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. , 2002, Brain : a journal of neurology.

[33]  Salvatore Mazza,et al.  Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. , 2011, Journal of Alzheimer's disease : JAD.

[34]  R. Cabeza Hemispheric asymmetry reduction in older adults: the HAROLD model. , 2002, Psychology and aging.

[35]  Hengyi Rao,et al.  Arterial spin-labeled perfusion MRI in basic and clinical neuroscience , 2009, Current opinion in neurology.

[36]  Joseph A Maldjian,et al.  Arterial transit time imaging with flow encoding arterial spin tagging (FEAST) , 2003, Magnetic resonance in medicine.

[37]  Hiroshi Matsuda,et al.  Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT* , 2007, Journal of Nuclear Medicine.